SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-106116
Filing Date
2024-09-12
Accepted
2024-09-12 19:31:50
Documents
2
Period of Report
2024-09-12

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4918
2 EX-24.POA mbx-ex24_poa.htm EX-24.POA 27920
  Complete submission text file 0000950170-24-106116.txt   34242
Mailing Address C/O MEDIMMUNE, INC. ONE MEDIMMUNE WAY GAITHERSBURG MD 20878
Business Address
Mathers Edward T (Reporting) CIK: 0001328625 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42272 | Film No.: 241296107

Mailing Address 12406 HORESHAM STREET CARMEL IN 46032
Business Address 12406 HORESHAM STREET CARMEL IN 46032 3179893100
MBX Biosciences, Inc. (Issuer) CIK: 0001776111 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)